Pharmacists assume the drugs they receive to dispense to patients are safe and legitimate, when in reality there hasn’t been a system to assure product integrity. This course reviews the new Drug Supply Chain Security Act (DSCSA), how to be compliant with the requirements, and how it will significantly impact the safety of drug products.

Upon successful completion of this knowledge-based CPE course, pharmacists should be able to:
1. Describe the role of the FDA in the assurance of pharmaceutical product integrity, as delegated to the agency through the federal Food Drug and Cosmetic Act, as amended by the Drug Supply Chain Security Act.
2. List factors that could significantly increase the risk of an illegitimate pharmaceutical product entering the drug supply chain.
3. Outline strategies for pharmacy compliance with the requirements established under the Drug Supply Chain
Security Act. 

David B. Brushwood, R.Ph, J.D.
Senior Lecturer, The University of Wyoming School of Pharmacy
Pharmacy Law Content Developer, CEimpact

David B. Brushwood does not report any actual or potential conflicts of interest in relation to this continuing pharmacy education course.

Course fee includes course, course, materials, and CPE credit submission to CPE Monitor.
Initial Release Date: March 18, 2022
Planned Expiration Date: March 18, 2025

This program is provided for educational purposes. CEimpact is not a law firm and does not provide legal advice of any kind. For legal advice, please contact a licensed attorney. 

Copyright 2022, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.

RV2-10.23